Gestational Diabetes Mellitus: NICE for the U.S.?

Diabetes Care - Tập 33 Số 1 - Trang 34-37 - 2010
David Simmons1, Aidan McElduff2, David McIntyre3, Mohamed Elrishi4
1Institute of Metabolic Science, Cambridge University Hospitals, National Health Services Foundation Trust, Cambridge, England;
2Northern Sydney Endocrine Centre, St Leonards, New South Wales, Australia;
3University of Queensland and Mater Health Services, South Brisbane, Queensland, Australia;
4Department of Diabetes and Endocrinology, The Princess Alexandra Hospital, National Health Services Trust, Essex, U.K.

Tóm tắt

OBJECTIVE To compare recent U.S. and U.K. guidelines on gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS The guidelines from the American Diabetes Association, the American College of Obstetricians and Gynecologists, and the National Institute for Health and Clinical Excellence (NICE) in the U.K. were collated and compared using a general inductive approach. RESULTS There are substantial differences in the recommendations between the U.K. and the U.S. guidelines. Of particular note are the reduced sensitivities of the early and later antenatal and postnatal screening and diagnostic criteria. NICE undertook a cost-effectiveness analysis using lower prevalence estimates and limited outcomes and still showed screening for GDM to be cost-effective. CONCLUSIONS The latest NICE recommendations appear to reduce access to proven, cost-effective management of GDM, an issue relevant in the current U.S. health care policy debate.

Từ khóa


Tài liệu tham khảo

Simmons, Epidemiological context of diabetes in pregnancy, A Practical Manual of Diabetes in Pregnancy, 1st ed.

Crowther, 2005, Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes on pregnancy outcomes, N Engl J Med, 352, 2477, 10.1056/NEJMoa042973

Ratner, 2007, Prevention of type 2 diabetes in women with previous gestational diabetes, Diabetes Care, 30, S242, 10.2337/dc07-s223

Moses, 2009, Universal screening for gestational diabetes, Diabetes Care, 32, 1349, 10.2337/dc09-0188

Berger, 2009, The case for selective screening, Diabetes Care, 32, 1352, 10.2337/dc09-0361

American Diabetes Association., 2003, Gestational diabetes mellitus, Diabetes Care, 26, s103, 10.2337/diacare.26.2007.S103

American College of Obstetricians and Gynecologists., 2001, Clinical American management guidelines for obstetrician-gynecologists: gestational diabetes: ACOG Practice Bulletin No. 30, Obstet Gynecol, 98, 525, 10.1097/00006250-200109000-00037

The Guideline Development Group., 2008, Guidelines: management of diabetes from preconception to the postnatal period: summary of NICE guidance, BMJ, 336, 714, 10.1136/bmj.39505.641273.AD

Mathiesen, 2008, Commentary from Copenhagen on the NICE guideline on management of diabetes and its complications from preconception to the postnatal period, Diabet Med, 25, 1028, 10.1111/j.1464-5491.2008.02531.x

Hillier, 2007, Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia, Diabetes Care, 30, 2287, 10.2337/dc06-2361

Pallardo, 1999, Early postpartum metabolic assessment in women with prior gestational diabetes, Diabetes Care, 22, 1053, 10.2337/diacare.22.7.1053

Kousta, 1999, Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes, Diabetes Care, 22, 933, 10.2337/diacare.22.6.933

McElduff, 2004, Fasting plasma glucose values alone miss most abnormalities of glucose tolerance in the postpartum, Diabet Med, 21, 648, 10.1111/j.1464-5491.2004.1210a.x

Feig, 2008, Risk of development of diabetes mellitus after diagnosis of gestational diabetes, CMAJ, 179, 229, 10.1503/cmaj.080012

HAPO Study Cooperative Research Group, 2008, Hyperglycemia and adverse pregnancy outcomes, N Engl J Med, 358, 1991, 10.1056/NEJMoa0707943

Thông tin
Thông tin xuất bản

Diabetes Care

Tập 33 Số 1

34-37

Thông tin tác giả